We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




NT-proBNP Aids Diagnosis of Heart Failure

By HospiMedica staff writers
Posted on 17 Mar 2005
In a study recently conducted by The New England Journal of Medicine (2005;352:666-75), NT-proBNP (N-terminal pro brain natriuretic peptide) was determined to be a marker of long-term mortality in patients with stable coronary heart disease. More...


The NT-proBNP test of Dade Behring (Deerfield, IL, USA; www.dadebehring.com) has been cleared by the U.S. Food and Drug Administration (FDA) for use on the company's Stratus CS Acute Care diagnostics system. The assay was cleared to aid in the diagnosis of heart failure, including assessment of heart failure severity in patients diagnosed with congestive heart failure, and risk stratification of patients with acute coronary syndrome and heart failure. In December 2004, clearance was received for the use of the test in the assessment of heart failure severity and risk stratification on the company's Dimension instruments with heterogeneous immunoassay module.

"We take our responsibility to our customers in the laboratories, and to the patients and physicians they serve very seriously, and we are pleased to provide another diagnostic tool in the treatment of cardiovascular disease, the number one cause of death across the world,” said Jim Reid-Anderson, chairman, president, and CEO, Dade Behring.





Related Links:
Dade Behring

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Surgical System
Stealth AXiS
Desk Aneroid Sphyg
Diagnostix 750D+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.